Oct 5, 2026 06:42AM
Aug 10, 2026 07:00AM
Aug 10, 2026 07:00AM
Jun 21, 2026 05:00PM
Jun 21, 2026 05:00PM
May 12, 2026 07:14AM
May 11, 2026 07:12AM Moonlake Immunotherapeutics (MLTX) PT Raised to $45 at H.C. Wainwright
May 10, 2026 09:00AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM
Mar 19, 2026 03:42AM
Feb 22, 2026 11:00AM MoonLake reports positive Phase 2 results for axial spondyloarthritis drug
Feb 22, 2026 11:00AM
Feb 3, 2026 06:45AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM
Jan 15, 2026 02:26AM
Jan 9, 2026 05:51AM
Jan 8, 2026 09:32AM Morning Market Pulse: From Orbit to Biomaterials, Innovation Drives the Tape
Jan 8, 2026 08:51AM
Jan 8, 2026 08:05AM
Jan 8, 2026 08:00AM
Nov 5, 2025 07:00AM
Sep 29, 2025 06:56AM
Sep 28, 2025 12:05PM
Sep 28, 2025 12:04PM MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
Sep 11, 2025 08:18AM
Aug 5, 2025 07:00AM
Aug 5, 2025 05:40AM
May 12, 2025 04:00PM
Apr 25, 2025 04:05PM
Apr 12, 2025 04:00AM
Feb 26, 2025 07:00AM MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Nov 7, 2024 07:00AM
Sep 9, 2024 07:00AM
Aug 7, 2024 08:00AM
Jun 10, 2024 08:00AM
Jun 10, 2024 07:02AM
May 7, 2024 08:00AM
Mar 10, 2024 12:00PM MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
Feb 29, 2024 08:00AM
Feb 29, 2024 08:00AM
Feb 26, 2024 08:02AM
Feb 26, 2024 08:00AM
Nov 14, 2023 08:00AM
Oct 15, 2023 09:03AM
Aug 10, 2023 07:00AM MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
Nov 14, 2022 08:00AM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All